Search Results

There are 18258 results for: content related to: Antiparkinsonian Effects of Novel Adenosine A 2A Receptor Antagonists

  1. Antipsychotic Prescribing Patterns and the Treatment of Extrapyramidal Symptoms in Older People

    Journal of the American Geriatrics Society

    Volume 43, Issue 9, September 1995, Pages: 967–973, Susan C. Kalish, Rhonda L. Bohn, Helen Mogun, Robert J. Glynn, Jerry H. Gurwitz and Jerry Avorn

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1995.tb05559.x

  2. Usefulness of Antiparkinsonian Drugs during Neuroleptic Treatment and the Effect of Clonazepam on Akathisia and Parkinsonism Occurred after Antiparkinsonian Drug Withdrawal: A Double-Blind Study

    Psychiatry and Clinical Neurosciences

    Volume 46, Issue 3, September 1992, Pages: 733–739, Jun Horiguchi and Ohichi Nishimatsu

    Version of Record online : 17 MAR 2008, DOI: 10.1111/j.1440-1819.1992.tb00549.x

  3. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  4. Antiparkinsonian agents and long-term neuroleptic treatment

    Acta Psychiatrica Scandinavica

    Volume 55, Issue 4, April 1977, Pages: 251–260, J. Gerlach, P. T. Rasmussen, L. Hansen and P. Kristjansen

    Version of Record online : 23 AUG 2007, DOI: 10.1111/j.1600-0447.1977.tb00170.x

  5. Effects of antiparkinsonian agents on β-amyloid and α-synuclein oligomer formation in vitro

    Journal of Neuroscience Research

    Volume 91, Issue 10, October 2013, Pages: 1371–1381, Kenjiro Ono, Jun-ichi Takasaki, Ryoichi Takahashi, Tokuhei Ikeda and Masahito Yamada

    Version of Record online : 1 AUG 2013, DOI: 10.1002/jnr.23256

  6. You have free access to this content
    Initiation of medications for Parkinson's disease: a qualitative description

    Journal of Clinical Nursing

    Volume 25, Issue 1-2, January 2016, Pages: 127–133, Ju Young Shin and Barbara Habermann

    Version of Record online : 30 SEP 2015, DOI: 10.1111/jocn.13009

  7. You have free access to this content
    Perphenazine for schizophrenia

    Intervention Review

    The Cochrane Library

    Benno Hartung, Stephanie Sampson and Stefan Leucht

    Published Online : 6 MAR 2015, DOI: 10.1002/14651858.CD003443.pub3

  8. Adenosine 2A Receptor Antagonists for the Treatment of Motor Symptoms in Parkinson's Disease

    Movement Disorders Clinical Practice

    Volume 2, Issue 4, December 2015, Pages: 331–340, Emmanuelle Pourcher and Philippe Huot

    Version of Record online : 25 JUL 2015, DOI: 10.1002/mdc3.12187

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 3, Issue 3, 320, Version of Record online: 1 JUN 2016

  9. Influence of benzodiazepines on antiparkinsonian drug treatment in levodopa users

    Acta Neurologica Scandinavica

    Volume 105, Issue 1, January 2002, Pages: 8–12, D. A. M. C. Van De Vijver, R. A. C. Roos, P. A. F. Jansen, A. J. Porsius and A. De Boer

    Version of Record online : 22 JAN 2002, DOI: 10.1034/j.1600-0404.2002.00132.x

  10. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  11. Mortality in a population-based cohort of patients treated with antiparkinsonian drugs

    Acta Neurologica Scandinavica

    Volume 97, Issue 1, January 1998, Pages: 20–26, R. Raschetti, S. Spila-Alegiani, N. Vanacore, C. Ancona and G. Meco

    Version of Record online : 29 JAN 2009, DOI: 10.1111/j.1600-0404.1998.tb00604.x

  12. The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates

    Movement Disorders

    Volume 25, Issue 13, 15 October 2010, Pages: 2084–2093, Tom H. Johnston, Susan H. Fox, Matthew J. Piggott, Juha-Matti Savola and Jonathan M. Brotchie

    Version of Record online : 7 SEP 2010, DOI: 10.1002/mds.23172

  13. Limitations of current Parkinson's disease therapy

    Annals of Neurology

    Volume 53, Issue S3, 2003, Pages: S3–S15, Olivier Rascol, Pierre Payoux, Fabienne Ory, Joaquim J. Ferreira, Christine Brefel-Courbon and Jean-Louis Montastruc

    Version of Record online : 24 MAR 2003, DOI: 10.1002/ana.10513

  14. IMPLICATIONS OF PHENOTHIAZINE SIDE EFFECTS: A STUDY OF ANTIPARKINSONIAN AGENTS IN AN OLDER POPULATION

    Acta Psychiatrica Scandinavica

    Volume 51, Issue 2, February 1975, Pages: 110–118, I. C. A. Martin

    Version of Record online : 23 AUG 2007, DOI: 10.1111/j.1600-0447.1975.tb00220.x

  15. Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease

    Annals of Neurology

    Volume 35, Issue 6, June 1994, Pages: 655–661, Dr. J. Timothy Greenamyre, Robert V. Eller, Zhiming Zhang, Aliza Ovadia, Roger Kurlan and Don M. Gash

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410350605

  16. Successful antiparkinsonian medication withdrawal in patients with Parkinsonism and normal FP-CIT SPECT

    Movement Disorders

    Volume 21, Issue 12, December 2006, Pages: 2247–2250, Vicky L. Marshall, Jim Patterson, Donald M. Hadley, Katherine A. Grosset and Donald G. Grosset

    Version of Record online : 31 OCT 2006, DOI: 10.1002/mds.21159

  17. You have free access to this content
    Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa

    British Journal of Clinical Pharmacology

    Volume 54, Issue 2, August 2002, Pages: 168–170, D. A. M. C. Van De Vijver, R. A. C. Roos, P. A. F. Jansen, A. J. Porsius and A. De Boer

    Version of Record online : 4 SEP 2002, DOI: 10.1046/j.1365-2125.2001.01491.x

  18. Effect of some antiparkinsonian drugs on catecholamine neurons

    Journal of Pharmacy and Pharmacology

    Volume 22, Issue 10, October 1970, Pages: 733–737, LARS-OVE FARNEBO, KJELL FUXE, BERTIL HAMBERGER and HÅKE LJUNGDAHL

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1970.tb08420.x

  19. Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, part II

    Annals of Neurology

    Volume 24, Issue 3, September 1988, Pages: 372–378, M. M. Mouradian, J. L. Junecos, G. Fabbrini, J. Schlegel, J. J. Bartko and Dr. T. N. Chase

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410240304

  20. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914